Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pidlich

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Prostaglandins|July 1, 1991
Effect of prostaglandin E1 on low density lipoprotein apo-B-receptor binding in human, rat and swine liver in vitroI Virgolini, S R Li, G Lupattelli, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Comparison of different methods for LDL isolation and radioiodination on liver LDL receptor binding in vitroI Virgolini, P Angelberger, G Lupattelli, et al.
Cancer|October 15, 1995
Phase I/II trial of dexverapamil, epirubicin, and granulocyte-macrophage-colony stimulating factor in patients with advanced pancreatic adenocarcinomaG Kornek, M Raderer, T Schenk, et al.
Journal of Hepatology|December 1, 1995
Elevated levels of serum carbohydrate deficient transferrin are not specific for alcohol abuse in patients with liver diseaseM Radosavljevic, E Temsch, J Hammer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1991
Indium-111-labeled low-density lipoprotein binds with higher affinity to the human liver as compared to iodine-123-low-density-labeled lipoproteinI Virgolini, P Angelberger, S R Li, et al.
European Journal of Clinical Investigation|October 10, 1998
Direct evidence for an increase in thrombopoiesis after liver transplantationG Stiegler, P Stohlawetz, M Peck-Radosavljevic, et al.
European Journal of Gastroenterology & Hepatology|November 27, 1998
Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trialC Müller, S Pongratz, J Pidlich, et al.
Atherosclerosis|September 1, 1993
Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemiaI Virgolini, E Koller, S Li, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1993
[Gender-specific differences of risk factors of atherosclerosis. A study of 3,850 Vienna employees]M Stelzeneder, K Weiss, R Katzenschlager, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 1997
Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular diseaseS R Li, Q Yang, E Koller, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Prostaglandins|July 1, 1991
Effect of prostaglandin E1 on low density lipoprotein apo-B-receptor binding in human, rat and swine liver in vitroI Virgolini, S R Li, G Lupattelli, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Comparison of different methods for LDL isolation and radioiodination on liver LDL receptor binding in vitroI Virgolini, P Angelberger, G Lupattelli, et al.
Cancer|October 15, 1995
Phase I/II trial of dexverapamil, epirubicin, and granulocyte-macrophage-colony stimulating factor in patients with advanced pancreatic adenocarcinomaG Kornek, M Raderer, T Schenk, et al.
Journal of Hepatology|December 1, 1995
Elevated levels of serum carbohydrate deficient transferrin are not specific for alcohol abuse in patients with liver diseaseM Radosavljevic, E Temsch, J Hammer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1991
Indium-111-labeled low-density lipoprotein binds with higher affinity to the human liver as compared to iodine-123-low-density-labeled lipoproteinI Virgolini, P Angelberger, S R Li, et al.
European Journal of Clinical Investigation|October 10, 1998
Direct evidence for an increase in thrombopoiesis after liver transplantationG Stiegler, P Stohlawetz, M Peck-Radosavljevic, et al.
European Journal of Gastroenterology & Hepatology|November 27, 1998
Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trialC Müller, S Pongratz, J Pidlich, et al.
Atherosclerosis|September 1, 1993
Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemiaI Virgolini, E Koller, S Li, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1993
[Gender-specific differences of risk factors of atherosclerosis. A study of 3,850 Vienna employees]M Stelzeneder, K Weiss, R Katzenschlager, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 1997
Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular diseaseS R Li, Q Yang, E Koller, et al.
Pageof 5